Mar. 30 at 2:51 AM
$GUTS Dr. Harith Rajagopalan, Chief Executive Officer, Fractyl Health: I want to address capital strategy directly and remove any ambiguity. We have closed our ATM facility, and we do not have plans to raise capital before we have pivotal data in hand. Our runway extends into early 2027. This is a deliberate commitment grounded in conviction. We expect the pivotal data will be positive, and we will operate with discipline within our existing capital envelope as a signal of management’s alignment with shareholders through a key moment.
What is clear is that the ablation length or weight effect is greater than or equal to 16 cm. That will be our operating standard going forward... We believe this to be the reason for heterogeneity that we saw back in January, and we’re very gratified to have the data to be able to give us clarity on the precision of what is needed in order to deliver benefit to patients... In the pivotal cohort, mean and median ablation length was greater than 16 cm.
